Who’s who of biopharma execs backs tiny Dutch startup’s bid to treat rare disease
Who’s who of biopharma execs backs tiny Dutch startup’s bid [...]
Déjà vu: Ampio’s stock sinks as FDA rejects COVID-19-ravaged osteoarthritis trial
Déjà vu: Ampio’s stock sinks as FDA rejects COVID-19-ravaged osteoarthritis [...]
Octant sets sail for new era of drug discovery with $80M funding, Bristol Myers partnership
Octant sets sail for new era of drug discovery with [...]
Novavax touts early data for flu-COVID combo vaccine as FDA decision looms for single shot
Novavax touts early data for flu-COVID combo vaccine as FDA [...]
UPDATE: Aptinyx pauses phase 2 trial of higher dose PTSD med to save cash
UPDATE: Aptinyx pauses phase 2 trial of higher dose PTSD [...]
Windtree’s phase 2 shock med rapidly raises blood pressure—and share price
Windtree’s phase 2 shock med rapidly raises blood pressure—and share [...]
Tessera Therapeutics stacks up more than $300M in series C funds to bolster new gene-editing platforms
Tessera Therapeutics stacks up more than $300M in series C [...]
Finch’s nest thins out with 20% of employees cut in restructuring after FDA hold
Finch’s nest thins out with 20% of employees cut in [...]
Imara eliminates 83% of workforce—including chief medical officer—in wake of pipeline wipeout
Imara eliminates 83% of workforce—including chief medical officer—in wake of [...]
Fore tees up new CEO, 5 months after ousting former chief executive on insider trading charges
Fore tees up new CEO, 5 months after ousting former [...]